September 18, 2026
"Not all patients will benefit equally from Enhertu, highlighting the need for personalized treatment plans."
15 秒了解背景
From the Daily Brief — uneven press attention Press coverage leaned toward left-leaning outlets.
Read the 2026-09-17 Daily BriefEnhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available
为什么提这个问题： This question comes from a story featured in the Daily Brief — where press attention was uneven or a story sat under the radar. Category: Healthcare. It reflects a recent development.
来源
New hope for breast cancer patients as life-extending drug now on NHS in England
BBC News · Sep 16, 2026
Women in England with incurable breast cancer to get life-extending drug on NHS
The Guardian · Sep 17, 2026
Life-extending breast cancer drug made available in England after U-turn
The Independent · Sep 17, 2026
只需不到 2 分钟。您的回应有助于形成共识信号。
先分享您的初步想法，然后投票后探索完整讨论和研究工具。还没想好？那也是个有效的答案。
WhatsApp
X
LinkedIn
Facebook
BlueSky
Telegram